Netrins are secreted proteins that regulate axon guidance and neuronal migration. DCC is a well-established Netrin-1 receptor mediating attractive responses. We provide evidence that its close relative neogenin is also a functional Netrin-1 receptor that acts with DCC to mediate guidance in vivo. We determined the structures of a functional Netrin-1 region, alone and in complexes with neogenin or DCC. Netrin-1 has a rigid elongated structure containing two receptor-binding sites at opposite ends through which it brings together receptor molecules. The ligand/receptor complexes reveal two distinct architectures: a 2:2 heterotetramer and a continuous ligand/receptor assembly. The differences result from different lengths of the linker connecting receptor domains FN4 and FN5, which differs among DCC and neogenin splice variants, providing a basis for diverse signaling outcomes.

SUMMARY The endothelial specific receptor tyrosine kinase Tie2, and the orphan receptor tyrosine kinase, Tie1, are essential for endothelial cell proliferation, migration, and survival during angiogenesis. Despite their considerable similarity, experiments with Tie1 or Tie2 deficient mice highlight distinct functions for these two receptors in vivo. However, Tie1 cooperates with Tie2 during Angiopoietin signaling, demonstrating a degree of functional overlap between the two receptor-systems. Tie2 is further unique among receptor tyrosine kinases with respect to its structurally homologous ligands. Angiopoietin-2 and -3 can function as agonists or antagonists depending upon the local environment, while Angiopoietin-1 and -4, are constitutive agonists. To address the role of Tie1 in Angiopoietin-mediated Tie2 signaling, and determine the basis for the unique behavior of the individual Angiopoietins, we used an in vivo FRET-based proximity assay to monitor Tie1 and Tie2 localization and association in the presence and absence of ligands. Here, we provide direct evidence for Tie1-Tie2 complex formation on the endothelial cell surface and identify molecular surface areas essential for receptor-receptor recognition. We further demonstrate that the Tie1-Tie2 interactions are dynamic, inhibitory, and differentially modulated by Angiopoietin-1 and -2, thereby providing a discrete molecular mechanism for the observed variations in Angiopoietin function. Based upon the available data, we propose a unified model for Angiopoietin-induced Tie2 signaling which highlights the essential role of Tie1 in vascular homeostasis.

The Tie receptor tyrosine kinases and their angiopoietin (Ang) ligands play central roles in developmental and tumor-induced angiogenesis. Here we present the crystal structures of the Tie2 ligand-binding region alone and in complex with Ang2. In contrast to prediction, Tie2 contains not two but three immunoglobulin (Ig) domains, which fold together with the three epidermal growth factor domains into a compact, arrowhead-shaped structure. Ang2 binds at the tip of the arrowhead utilizing a lock-and-key mode of ligand recognition-unique for a receptor kinase-where two complementary surfaces interact with each other with no domain rearrangements and little conformational change in either molecule. Ang2-Tie2 recognition is similar to antibody-protein antigen recognition, including the location of the ligand-binding site within the Ig fold. Analysis of the structures and structure-based mutagenesis provide insight into the mechanism of receptor activation and support the hypothesis that all angiopoietins interact with Tie2 in a structurally similar manner.

Eph receptor tyrosine kinases and their ephrin ligands mediate cell signaling during normal and oncogenic development. Eph signaling is initiated in a multistep process leading to the assembly of higher-order Eph/ephrin clusters that set off bidirectional signaling in interacting cells. Eph and ephrins are divided in two subclasses based on their abilities to bind and activate each other and on sequence conservation. EphA4 is an exception to the general rule because it can be activated by both A-and B-class ephrin ligands. Here we present high-resolution structures of the complete EphA4 ectodomain and its complexes with ephrin-A5. The structures reveal how ligand binding promotes conformational changes in the EphA4 ligand-binding domain allowing the formation of signaling clusters at the sites of cell-cell contact. In addition, the structural data, combined with structure-based mutagenesis, reveal a previously undescribed receptor-receptor interaction between the EphA4 ligand-binding and membrane-proximal fibronectin domains, which is functionally important for efficient receptor activation.crystallography | phosphorylation | protein | transmembrane E ph receptors, the largest family of receptor tyrosine kinases, and their ephrin ligands regulate a variety of cell-cell interactions during development and in the adult organism (1-3). Because both receptors and ligands are membrane-bound, their interactions at sites of cell-cell contact initiate unique bidirectional signaling cascades (4). The signaling downstream of the Eph is referred to as "forward," and the signaling downstream of the ephrins is referred to as "reverse."The 16 Eph receptors and 9 ephrins are divided into two subclasses based on sequence homology and binding affinities. Receptor-ligand binding within each subclass is fairly promiscuous, whereas cross-subclass signaling happens rarely (5). The best-known exception to this general rule is EphA4, which has long been known to bind and be activated by both A-and B-class ligands (6, 7). Because of its unique properties, EphA4 is an attractive target for studying the structural details of subclass specificity (8).Eph and ephrins were originally identified as axon guidance molecules; they have now been implicated in a vast array of cell communication events. Those include bone morphogenesis and homeostasis, immunological and inflammatory host responses, stem cell plasticity, learning and memory, and Alzheimer's disease (9). However, currently, the most intensely studied function of the Eph/ephrin system is that during development and progression of different cancers. Many A-and B-class receptors were shown to be overexpressed in various tumor types (10-13) and to regulate critical steps of blood vessel formation (vasculogenesis) and remodeling (angiogenesis) and hence tumor growth.Structural studies on the minimal binding domains of Eph receptors and ephrins revealed important details of receptorligand recognition (2, 14). The initial binding force comes from a penetration of a long, hydrophobic ephrin...

Angiogenesis is a complex cellular process involving multiple regulatory growth factors and growth factor receptors. Among them, the ligands for the endothelial-specific tunica intima endothelial receptor tyrosine kinase 2 (Tie2) receptor kinase, angiopoietin-1 (Ang1) and Ang2, play essential roles in balancing vessel stability and regression during both developmental and tumorinduced angiogenesis. Despite possessing a high degree of sequence identity, Ang1 and Ang2 have distinct functional roles and cellsignaling characteristics. Here, we present the crystal structures of Ang1 both unbound and in complex with the Tie2 ectodomain.Comparison of the Ang1-containing structures with their Ang2-containing counterparts provide insight into the mechanism of receptor activation and reveal molecular surfaces important for interactions with Tie2 coreceptors and associated signaling proteins. Using structure-based mutagenesis, we identify a loop within the angiopoietin P domain, adjacent to the receptor-binding interface, which confers the specific agonist/antagonist properties of the molecule. We demonstrate using cell-based assays that an Ang2 chimera containing the Ang1 loop sequence behaves functionally similarly to Ang1 as a constitutive Tie2 agonist, able to efficiently dissociate the inhibitory Tie1/Tie2 complex and elicit Tie2 clustering and downstream signaling. cellular signaling | Tie receptor tyrosine kinase | X-ray crystallography P roper development of the cardiovascular system involves two highly integrated and dynamic processes: vasculogenesis and angiogenesis (1). Vasculogenesis involves the in situ differentiation of endothelial cells from precursor angioblasts and results in their subsequent migration and proliferation, leading to the formation of the endocardium of the heart, as well as the major primitive blood vessels (2-6). Angiogenesis occurs following vasculogenesis and results in the remodeling and extension of the endothelial tubes into the adult microvasculature, as well as in the growth and expansion of vessels into organs including the kidney and brain. Endothelial cells lining these newly formed vessels are surrounded by support cells, such as smooth muscle cells and pericytes, which serve to regulate blood flow and provide survival signals (7). Angiogenesis predominantly takes place during embryonic development, although it also recurs during wound repair in adulthood. Its role is essential for tumor development, as well as metastasis and, therefore, represents a viable target for therapeutic intervention (8).The angiopoietins are a small set of growth factor ligands for the tunica intima endothelial receptor tyrosine kinase 2 (Tie2) endothelial-specific receptor tyrosine kinase and are critical for both development and pathological angiogenesis (9-11). The prototypic family member, angiopoietin-1 (Ang1), is a Tie2 agonist, whereas the highly homologous Ang2 is a context-dependent agonist/antagonist. All angiopoietin family members, Ang1 to -4, contain an amino-terminal "superclustering" and...